Mario Tadeo, Bloomberg News EMEA Reporter, will discuss the latest on Brexit. Troy Gayeski, Co-Chief Investment Officer at Skybridge, will discuss the current developments in the China trade war and its impact on markets. Max Nisen, Bloomberg Healthcare Columnist, will discuss news that the three largest U.S. drug distributors and a major generic-drug manufacturer, have agreed to pay more than $250 million to settle the first federal trial over the companies’ role in fueling the U.S. opioid epidemic. Derek Forbes, CEO of Stardust, on how interactive consumer tech allows businesses to develop a deeper understanding of their customers.

<p>Mario Tadeo, Bloomberg News EMEA Reporter, will discuss the latest on Brexit. Troy Gayeski, Co-Chief Investment Officer at Skybridge, will discuss the current developments in the China trade war and its impact on markets. Max Nisen, Bloomberg Healthcare Columnist, will discuss news that the three largest U.S. drug distributors and a major generic-drug manufacturer, have agreed to pay more than $250 million to settle the first federal trial over the companies’ role in fueling the U.S. opioid epidemic. Derek Forbes, CEO of Stardust, on how interactive consumer tech allows businesses to develop a deeper understanding of their customers.</p>

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

<p>Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p>

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Brexit, Trade, Consumer Tech

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/52345b81-4389-4764-96b1-ae3c004ecd16/transcript

Advertisement